新型血清生物标志物鉴别银屑病关节炎与银屑病
本病例对照研究纳入100例银屑病关节炎(PsA)、100例无关节炎的银屑病(PsC)及100例健康对照,检测M2BP、CD5L、MPO、ITGβ5、MMP-3与CRP水平。ITGβ5、M2BP与CRP联合模型区分PsA与PsC的AUC为0.85,优于单用CRP的0.71。
要点
- ITGβ5、M2BP与CRP联合模型区分PsA与PsC的AUC达0.85。
- 单用CRP区分PsA与PsC的AUC仅为0.71。
- CD5L、M2BP、MPO与单纯银屑病独立相关,或有助于筛查转诊。
核心结论
- ITGβ5、M2BP与CRP联合可区分PsA与PsC,且优于单用CRP。
研究设计与样本
- 病例对照研究,纳入100例PsA、100例PsC和100例健康对照,PsA与PsC按年龄、性别、银屑病病程及PASI匹配,且未接受生物制剂治疗。
- 采用酶联免疫吸附试验检测M2BP、CD5L、MPO、ITGβ5、MMP-3及CRP,以逻辑回归分析并绘制ROC曲线。
主要发现
- 与对照相比,CD5L、ITGβ5、M2BP、MPO、MMP-3和CRP水平均与PsA独立相关。
- 与对照相比,仅CD5L、M2BP和MPO与单纯PsC独立相关。
- 与PsC相比,ITGβ5、M2BP和CRP水平与PsA独立相关。
关键数值与推荐
- 区分PsA与PsC的联合模型AUC为0.85(95%CI 0.80-0.90)。
- 单用CRP的模型AUC为0.71(95%CI 0.64-0.78)。
临床怎么用
- 对银屑病患者可考虑检测ITGβ5、M2BP与CRP以辅助识别需风湿科转诊的PsA患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: There is a high prevalence of undiagnosed psoriatic arthritis (PsA) in patients with psoriasis. Identifying soluble biomarkers for PsA will help in screening psoriasis patients for appropriate rheumatology referral. We therefore aimed to investigate whether serum levels of novel markers previously discovered by quantitative mass spectrometric analysis of synovial fluid and skin biopsies performs better than the C-reactive protein (CRP) level in differentiating PsA patients from those with psoriasis without PsA (PsC). METHODS: In this case-control study, serum samples were obtained from 100 subjects with PsA, 100 with PsC, and 100 healthy controls. Patients with PsA and PsC were group matched for age, sex, psoriasis duration, and Psoriasis Area and Severity Index and were not currently receiving biologic treatment. Using enzyme-linked immunosorbent assay, 4 high-priority markers (Mac-2-binding protein [M2BP], CD5-like protein [CD5L], myeloperoxidase [MPO], and integrin β5 [ITGβ5]), as well as previously established markers (matrix metalloproteinase 3 [MMP-3] and CRP level) were assayed. Data were analyzed using logistic regression. Receiver operating characteristic (ROC) curves were plotted. RESULTS: In comparisons to controls, CD5L, ITGβ5, M2BP, MPO, MMP-3, and CRP level were independently associated with PsA, while only CD5L, M2BP, and MPO were independently associated with PsC alone. In comparisons to PsC, ITGβ5, M2BP, and CRP level were independently associated with PsA. ROC analysis of this model shows an area under the curve (AUC) of 0.85 (95% confidence interval [95% CI] 0.80-0.90). The model that included CRP level alone had an AUC of 0.71 (95% CI 0.64-0.78). CONCLUSION: CD5L, ITGβ5, M2BP, MPO, MMP-3, and CRP level are markers for PsA. The combination of ITGβ5, M2BP, and CRP level differentiates PsA from PsC, and performs better than CRP level alone.
引用
- Cretu D, Gao L, Liang K, et al. Differentiating Psoriatic Arthritis From Psoriasis Without Psoriatic Arthritis Using Novel Serum Biomarkers. Arthritis Care Res (Hoboken). 2018. PMID: 28586166. doi:10.1002/acr.23298
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。